These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 29387591)

  • 1. Current knowledge on psoriasis and autoimmune diseases.
    Ayala-Fontánez N; Soler DC; McCormick TS
    Psoriasis (Auckl); 2016; 6():7-32. PubMed ID: 29387591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities.
    Golden JB; McCormick TS; Ward NL
    Cytokine; 2013 May; 62(2):195-201. PubMed ID: 23562549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell responses in psoriasis and psoriatic arthritis.
    Diani M; Altomare G; Reali E
    Autoimmun Rev; 2015 Apr; 14(4):286-92. PubMed ID: 25445403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermal injection of immunocytes induces psoriasis.
    Wrone-Smith T; Nickoloff BJ
    J Clin Invest; 1996 Oct; 98(8):1878-87. PubMed ID: 8878440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161.
    Nickoloff BJ; Wrone-Smith T; Bonish B; Porcelli SA
    Arch Dermatol; 1999 May; 135(5):546-52. PubMed ID: 10328195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy.
    Rácz E; Prens EP
    Expert Rev Mol Med; 2009 Dec; 11():e38. PubMed ID: 20003607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Angiogenic Growth Factors in Psoriasis: A Review.
    Akhtar T; Wani WY; Kamal MA; Kaur R
    Curr Drug Metab; 2018; 19(11):910-916. PubMed ID: 29663878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
    Coates LC; FitzGerald O; Helliwell PS; Paul C
    Semin Arthritis Rheum; 2016 Dec; 46(3):291-304. PubMed ID: 27388027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis.
    Nickoloff BJ
    J Investig Dermatol Symp Proc; 2000 Dec; 5(1):67-73. PubMed ID: 11147678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.
    Abrams JR; Kelley SL; Hayes E; Kikuchi T; Brown MJ; Kang S; Lebwohl MG; Guzzo CA; Jegasothy BV; Linsley PS; Krueger JG
    J Exp Med; 2000 Sep; 192(5):681-94. PubMed ID: 10974034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics for the primary care physician: Review and treatment of psoriasis.
    Schadler ED; Ortel B; Mehlis SL
    Dis Mon; 2019 Mar; 65(3):51-90. PubMed ID: 30037762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.
    Blauvelt A; Chiricozzi A
    Clin Rev Allergy Immunol; 2018 Dec; 55(3):379-390. PubMed ID: 30109481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
    Bellinger DL; Lorton D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-Presenting Cells in Psoriasis.
    Antal D; Alimohammadi S; Bai P; Szöllősi AG; Szántó M
    Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis mediated by cytolytic molecules might be responsible for maintenance of psoriatic plaques.
    Kastelan M; Massari LP; Brajac I
    Med Hypotheses; 2006; 67(2):336-7. PubMed ID: 16563649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.
    Cooper KD; Baadsgaard O; Ellis CN; Duell E; Voorhees JJ
    J Invest Dermatol; 1990 May; 94(5):649-56. PubMed ID: 2324521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.
    Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1995 Jul; 105(1 Suppl):89S-94S. PubMed ID: 7616005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances.
    Samotij D; Nedoszytko B; Bartosińska J; Batycka-Baran A; Czajkowski R; Dobrucki IT; Dobrucki LW; Górecka-Sokołowska M; Janaszak-Jasienicka A; Krasowska D; Kalinowski L; Macieja-Stawczyk M; Nowicki RJ; Owczarczyk-Saczonek A; Płoska A; Purzycka-Bohdan D; Radulska A; Reszka E; Siekierzycka A; Słomiński A; Słomiński R; Sobalska-Kwapis M; Strapagiel D; Szczerkowska-Dobosz A; Szczęch J; Żmijewski M; Reich A
    Postepy Dermatol Alergol; 2020 Apr; 37(2):135-153. PubMed ID: 32489346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.